Elutia announces private placement for proceeds up to $26 million

– combined proceeds of financing and orthobiologics divestiture potentially top $60 million – silver spring, md., sept. 19, 2023 (globe newswire) -- elutia inc. (nasdaq: elut) (“elutia”), a company pioneering drug-eluting biomatrix products, today announced that it has entered into a securities purchase agreement for a private placement (pipe) financing that is expected to result in initial gross proceeds to the company of approximately $10.5 million, before deducting offering expenses.
ELUT Ratings Summary
ELUT Quant Ranking